Lanzi C - Search Results

1

Supersulfated low-molecular weight heparin synergizes with IGF1R/IR inhibitor to suppress synovial sarcoma growth and metastases.

Cassinelli G, Dal Bo L, Favini E, Cominetti D, Pozzi S, Tortoreto M, De Cesare M, Lecis D, Scanziani E, Minoli L, Naggi A, Vlodavsky I, Zaffaroni N, Lanzi C. Cassinelli G, et al. Among authors: lanzi c. Cancer Lett. 2018 Feb 28;415:187-197. doi: 10.1016/j.canlet.2017.12.009. Epub 2017 Dec 7. Cancer Lett. 2018. PMID: 29225052

2

Decreased drug accumulation and increased tolerance to DNA damage in tumor cells with a low level of cisplatin resistance.

Lanzi C, Perego P, Supino R, Romanelli S, Pensa T, Carenini N, Viano I, Colangelo D, Leone R, Apostoli P, Cassinelli G, Gambetta RA, Zunino F. Lanzi C, et al. Biochem Pharmacol. 1998 Apr 15;55(8):1247-54. doi: 10.1016/s0006-2952(97)00599-6. Biochem Pharmacol. 1998. PMID: 9719480

3

Inhibition of transforming activity of the ret/ptc1 oncoprotein by a 2-indolinone derivative.

Lanzi C, Cassinelli G, Pensa T, Cassinis M, Gambetta RA, Borrello MG, Menta E, Pierotti MA, Zunino F. Lanzi C, et al. Int J Cancer. 2000 Feb 1;85(3):384-90. Int J Cancer. 2000. PMID: 10652431

4

Clavilactones, a novel class of tyrosine kinase inhibitors of fungal origin.

Cassinelli G, Lanzi C, Pensa T, Gambetta RA, Nasini G, Cuccuru G, Cassinis M, Pratesi G, Polizzi D, Tortoreto M, Zunino F. Cassinelli G, et al. Among authors: lanzi c. Biochem Pharmacol. 2000 Jun 15;59(12):1539-47. doi: 10.1016/s0006-2952(00)00278-1. Biochem Pharmacol. 2000. PMID: 10799650

5

Structure elucidation of clavilactone D: an inhibitor of protein tyrosine kinases.

Merlini L, Nasini G, Scaglioni L, Cassinelli G, Lanzi C. Merlini L, et al. Among authors: lanzi c. Phytochemistry. 2000 Apr;53(8):1039-41. doi: 10.1016/s0031-9422(99)00506-3. Phytochemistry. 2000. PMID: 10820827

6

A role for loss of p53 function in sensitivity of ovarian carcinoma cells to taxanes.

Cassinelli G, Supino R, Perego P, Polizzi D, Lanzi C, Pratesi G, Zunino F. Cassinelli G, et al. Among authors: lanzi c. Int J Cancer. 2001 Jun 1;92(5):738-47. doi: 10.1002/1097-0215(20010601)92:5<738::aid-ijc1249>3.0.co;2-2. Int J Cancer. 2001. PMID: 11340581

7

Cell cycle checkpoint efficiency and cellular response to paclitaxel in prostate cancer cells.

Lanzi C, Cassinelli G, Cuccuru G, Supino R, Zuco V, Ferlini C, Scambia G, Zunino F. Lanzi C, et al. Prostate. 2001 Sep 15;48(4):254-64. doi: 10.1002/pros.1105. Prostate. 2001. PMID: 11536305

8

Cellular bases of the antitumor activity of the novel taxane IDN 5109 (BAY59-8862) on hormone-refractory prostate cancer.

Cassinelli G, Lanzi C, Supino R, Pratesi G, Zuco V, Laccabue D, Cuccuru G, Bombardelli E, Zunino F. Cassinelli G, et al. Among authors: lanzi c. Clin Cancer Res. 2002 Aug;8(8):2647-54. Clin Cancer Res. 2002. PMID: 12171897

9

IDN 5390: an oral taxane candidate for protracted treatment schedules.

Pratesi G, Laccabue D, Lanzi C, Cassinelli G, Supino R, Zucchetti M, Frapolli R, D'Incalci M, Bombardelli E, Morazzoni P, Riva A, Zunino F. Pratesi G, et al. Among authors: lanzi c. Br J Cancer. 2003 Mar 24;88(6):965-72. doi: 10.1038/sj.bjc.6600784. Br J Cancer. 2003. PMID: 12644838 Free PMC article.

10

Inactivation of Ret/Ptc1 oncoprotein and inhibition of papillary thyroid carcinoma cell proliferation by indolinone RPI-1.

Lanzi C, Cassinelli G, Cuccuru G, Zaffaroni N, Supino R, Vignati S, Zanchi C, Yamamoto M, Zunino F. Lanzi C, et al. Cell Mol Life Sci. 2003 Jul;60(7):1449-59. doi: 10.1007/s00018-003-2381-8. Cell Mol Life Sci. 2003. PMID: 12943231 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters